Cost of eradication treatment may have been overestimated

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7057.622b (Published 07 September 1996) Cite this as: BMJ 1996;313:622
  1. N R Waugh
  1. Director Scottish Health Purchasing Information Centre, Summerfield House, Aberdeen AB15 ORE

    EDITOR,—The paper by A H Briggs et al is a useful contribution to the debate about the management of dyspepsia.1 However, some of their assumptions may have overestimated the cost of eradication and underestimated the cost of treatment with H2 receptor antagonists.

    The costs of H2 antagonists were based on cimetidine. Scottish prescribing …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription